Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Hemodynamic Response in Hypertensive Intubation
NCT06712186Phase 2Recruiting
- Sponsor
- Liaquat National Hospital & Medical College
- Start
- Jun 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in hypertension (HTN) (2 arms), sponsored by Liaquat National Hospital & Medical College. Primary endpoint: Mean Arterial Pressure. Started Jun 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06712186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06712186.